Bristol-Myers Squibb

Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
M&A
Amgen
ONYX Pharmaceuticals
Bausch & Lomb
Valeant Pharmaceuticals
Elan
Perrigo
Actavis
Warner Chilcott
Bristol-Myers Squibb
AstraZeneca
Pearl Therapeutics
Agila
Mylan
Salix
Santarus
Bayer
Algeta
Shire
ViroPharma
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?
Motley Fool
Tue, 04/15/14 - 10:36 am
hepatitis C
Gilead Sciences
Sovaldi
Merck
Bristol-Myers Squibb
daclatasvir
asunaprevir
MK-5172
MK-8742
Encouraging Data from Bristol-Myers
Yahoo/Zacks
Sat, 04/12/14 - 10:20 am
Bristol-Myers Squibb
HCV
hepatitis
hepatitis C
daclatasvir
asunaprevir
Doctors welcome hepatitis C drug rivals, Gilead still leads
Yahoo/Reuters
Fri, 04/11/14 - 08:47 am
physicians
hepatitis C
Gilead Sciences
Sovaldi
Merck
AbbVie
Bristol-Myers Squibb
Bristol-Myers hepatitis C treatment cures up to 90 pct -study
Yahoo/Zacks.com
Thu, 04/10/14 - 07:35 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
asunaprevir
Bristol-Myers submits NDAs for Hep C drugs
Seeking Alpha
Mon, 04/7/14 - 09:57 am
Bristol-Myers Squibb
daclatasvir
asunaprevir
hepatitis C
FDA
After Bristol Myers' Bydureon Success, The Next Step Is Sustained Release Insulin
Seeking Alpha
Wed, 04/2/14 - 09:52 pm
Bydureon
insulin
Bristol-Myers Squibb
diabetes
3 Stocks Pushing The Drugs Industry Lower
TheStreet.com
Tue, 04/1/14 - 03:01 pm
Bristol-Myers Squibb
Merck
Pfizer
Pfizer, Bristol-Myers announce results of subanalysis of Phase 3 ARISTOTLE trial
Yahoo/Fly on the Wall
Thu, 03/27/14 - 10:57 am
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Bristol Myers Deal Overshadows Q4 loss at Five Prime
Yahoo/Zacks.com
Thu, 03/27/14 - 10:48 am
earnings
Bristol-Myers Squibb
Five Prime
Gene Therapy's Big Comeback
Forbes
Wed, 03/26/14 - 08:07 am
gene therapy
Bristol-Myers Squibb
Bluebird Bio
NightstaRx
Voyager Therapeutics
uniQure
Celladon
Juno Therapeutics
Editas Medicine
Gensight Biologics
Audentes Therapeutics
Dimension Therapeutics
Who's going to win pharma's immunotherapy gold rush?
Fierce Biotech
Tue, 03/25/14 - 08:08 am
immunotherapy
Roche
Bristol-Myers Squibb
Merck
PDL-1
anti-PD-1 immunotherapy
melanoma
Bristol-Myers, Roche, working on possible blockbusters for melanoma, WSJ says
Yahoo/Fly on the Wall
Mon, 03/24/14 - 08:50 am
Bristol-Myers Squibb
Roche
melanoma
AstraZeneca
Big Pharma Ramps Up Hep C Strategies
Yahoo/Investors Business Daily
Wed, 03/19/14 - 07:22 pm
hepatitis C
Sovaldi
Gilead Sciences
daclatasvir
Bristol-Myers Squibb
AbbVie
Enanta Pharmaceuticals
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Fierce Biotech
Mon, 03/17/14 - 10:53 am
MK-3475
Merck
Five Prime
cancer immunotherapy
Bristol-Myers Squibb
Bristol-Myers' Eliquis gets new FDA nod for use after ortho surgery
Fierce Pharma
Mon, 03/17/14 - 10:49 am
Eliquis
FDA
Bristol-Myers Squibb
Pfizer
knee replacement
hip replacements
FDA Grants New Indication For Pfizer/Bristol Anticoagulant
Forbes
Sat, 03/15/14 - 10:12 am
Pfizer
DVT
Bristol-Myers Squibb
Apixaban
anticoagulants
Eliquis
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
Yahoo/24-7 Wall St
Mon, 03/10/14 - 10:13 am
Eli Lilly
Bristol-Myers Squibb
Merck
Pfizer
Yervoy
palbociclib
animal health
ramucirumab
Can Bristol-Myers Squibb Keep Its Bull Run Going in 2014?
Motley Fool
Sat, 03/8/14 - 10:37 am
Bristol-Myers Squibb
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment
Marketwatch
Tue, 03/4/14 - 10:21 pm
Bristol-Myers Squibb
Yervoy
lung cancer

Pages